Case Reports in Gastroenterology

Published: October 2011

Open Access Gateway

Gastric Marginal Zone B Cell Lymphoma of the Duodenum

Ndzengue A.a · Khurana R.a · Mora M.a · Rafal R.B.b · Trauber D.a · Mansour M.a · Posner G.L.a · Jaffe E.A.a

Author affiliations

Departments of aMedicine and bRadiology, Interfaith Medical Center, Brooklyn, N.Y., USA

Corresponding Author

Albert Ndzengue, MD

Department of Medicine, Interfaith Medical Center

1545 Atlantic Avenue, Brooklyn, NY 11213 (USA)

Tel. +1 718 613 4063

Related Articles for ""

Case Rep Gastroenterol 2011;5:578–582

Abstract

Small bowel lymphomas of the extranodal type occur in the young and are characteristically associated with malabsorption syndrome. We present the case of an elderly in whom there was no malabsorption and the duodenal tumor was a gastric type marginal zone B cell lymphoma also known as gastric mucosa-associated lymphoid tissue (MALT) lymphoma. A 73-year-old woman presented to the emergency room with 2 weeks of general weakness, recurrent vomiting containing food particles and abdominal distension. She had been diagnosed with diabetic gastroparesis 4 years prior. CT of the abdomen and pelvis was suggestive of gastric outlet obstruction but no evidence of pancreatic or duodenal mass. Endoscopy and biopsy of the tumor obstructing the distal first part of the duodenum confirmed a gastric marginal MALT lymphoma. The patient’s symptoms improved with radiotherapy. Gastric MALT lymphoma, an extranodal lymphoma primarily described in the stomach, can also present in the small bowel and is not associated with malabsorption.

© 2011 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Published: October 2011

Published online: October 01, 2011
Issue release date: September – December

Number of Print Pages: 5
Number of Figures: 3
Number of Tables: 0


eISSN: 1662-0631 (Online)

For additional information: https://www.karger.com/CRG


Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP